P08709 (FA7_HUMAN) Homo sapiens (Human)
Coagulation factor VII UniProtKBInterProInteractive Modelling
466 aa; Sequence (Fasta) ; (Isoform 2)
Available Structures
112 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of the super-active FVIIa variant VYT in complex with tissue factor |
Heteromer P13726; | 100 | 1×BGC; 9×CA; 1×FUC; 10×TMA; 1×0Z7; | |||
| Crystal Structure of a FVIIa-Trypsin Chimera (FT) in Complex with Soluble Tissue Factor |
Heteromer P13726; | 100 | 1×BGC; 9×CA; 1×FUC; 22×TMA; 1×0Z7; 1×POL; | |||
| Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-D… |
Heteromer P13726; | 100 | 1×BGC; 1×FUC; 3×MG; 6×CA; 1×BEN; 1×NA; 2×CL; | |||
| Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in … |
Heteromer P13726; | 100 | 1×GLC; 1×FUC; 3×MG; 6×CA; 1×NA; 2×ZN; 3×CL; 1×PBZ; | |||
| Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-D… |
Heteromer P13726; | 100 | 1×BGC; 1×FUC; 2×MG; 7×CA; 1×0GE; 3×CL; 1×NA; | |||
| Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex. |
Heteromer P13726; | 100 | 1×GLC; 1×FUC; 3×MG; 6×CA; 1×NA; 2×ZN; 3×CL; 1×BEN; | |||
| Crystal structure analysis of human Factor VIIa , Souluble tissue factor complexed with BCX-3607 |
Heteromer P13726; | 100 | 1×ASO; 1×FUC; 9×CA; 1×24X; | |||
| Crystal Structure of a ternary complex of Factor VIIa/Tissue Factor/Pyrazinone Inhibitor |
Heteromer P13726; | 100 | 2×CA; 1×MG; 1×PY3; | |||
| Complex of active site inhibited human blood coagulation factor VIIA with human recombinant soluble… |
Heteromer P13726; | 100 | 1×BGC; 1×FUC; 9×CA; 1×0Z6; 1×CAC; 1×CL; | |||
| Crystal structure of DFPR-VIIa/sTF |
Heteromer P13726; | 100 | 1×GLC; 1×FUC; 3×MG; 6×CA; 1×0G7; 1×NA; 2×ZN; 3×CL; | |||
| Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzam… |
Heteromer P13726; | 100 | 1×BGC; 1×FUC; 9×CA; 1×3BP; | |||
| Human factor viia-tissue factor complexed with highly selective peptide inhibitor |
Heteromer P13726; | 100 | 1×BGC; 1×FUC; 9×CA; 1×567; | |||
| Crystal Structure of a FVIIa-Trypsin Chimera (ST) in Complex with Soluble Tissue Factor |
Heteromer P13726; | 100.0 | 8×CA; 1×BGC; 1×FUC; 1×0Z6; 2×CAC; | |||
| Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine |
Heteromer P13726; | 100 | 1×BGC; 1×FUC; 9×CA; 1×P5B; | |||
| BCX2627 complexed with human FVIIa and soluble Tissue Factor. |
Heteromer P13726; | 100 | 1×BGC; 1×FUC; 9×CA; 1×XGX; | |||
| Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine |
Heteromer P13726; | 100 | 1×BGC; 1×FUC; 9×CA; 1×PSM; | |||
| Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-… |
Heteromer P13726; | 100 | 1×BGC; 1×FUC; 9×CA; 1×359; | |||
| tf7a_3771 complex |
Heteromer P13726; | 100.0 | 1×771; 9×CA; 1×CAC; 1×FUC; 1×BGC; | |||
| Crystal structure of a ternary complex of factor VIIa/tissue factor and 2-[[6-[3-(aminoiminomethyl)… |
Heteromer P13726; | 100 | 8×CA; 1×CAC; 1×03R; | |||
| Human Factor Viia-Tissue Factor in Complex with peptide-mimetic inhibitor that has two charged grou… |
Heteromer P13726; | 100 | 1×BGC; 1×FUC; 9×CA; 1×3CB; | |||
| Human factor viia-tissue factor complexed with benzylsulfonamide-D-ile-gln-P-aminobenzamidine |
Heteromer P13726; | 100 | 1×BGC; 1×FUC; 9×CA; 1×PI0; | |||
| Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamid… |
Heteromer P13726; | 100 | 1×BGC; 1×FUC; 9×CA; 1×5PI; | |||
| Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex |
Heteromer P13726; | 100 | 1×GLC; 1×FUC; 6×CA; 2×MG; 1×0GJ; 1×NA; 2×ZN; 3×CL; | |||
| tf7a_4380 complex |
Heteromer P13726; | 100.0 | 1×380; 9×CA; 1×CAC; 1×FUC; 1×BGC; | |||
| CRYSTAL STRUCTURE OF FVIIA IN COMPLEX WITH A BENZAMIDINE-BASED INHIBITOR |
Heteromer P13726; | 100 | 4×CA; 1×MG; 1×GLC; 1×FUC; 1×WIZ; 2×CL; | |||
| Rubidium Sites in Blood Coagulation Factor VIIa |
Heteromer P13726; | 100 | 1×BGC; 1×FUC; 3×MG; 4×CA; 6×RB; 1×BEN; 4×CL; | |||
| CRYSTAL STRUCTURE OF FVIIA IN COMPLEX WITH A BENZAMIDINE-BASED INHIBITOR |
Heteromer P13726; | 100 | 2×CA; 1×MG; 1×GLC; 1×FUC; 2×CL; 1×WSV; | |||
| crystal structure of factor VII.stf complexed with pd0297121 |
Heteromer P13726; | 100 | 5×CA; 1×GIL; 1×GLC; 1×FUC; 1×NAG; | |||
| HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT |
Heteromer P00974; P13726; | 100 | 1×GLC; 1×FUC; 2×CA; | |||
| Crystal Structure of the Complex Between the Peptide Exosite Inhibitor E-76 and Coagulation Factor … |
Heteromer | 100 | 1×BGC; 1×0Z6; 2×CA; 1×CAC; 2×FUC; | |||
| Discovery of a Novel Hydroxy Pyrazole Based Factor IXa Inhibitor |
Heteromer P13726; | 100 | 1×6NH; | |||
| Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala1… |
Heteromer P13726; | 100 | 1×CR9; | |||
| Novel 5-Azaindole Factor VIIa Inhibitors |
Heteromer P13726; | 100 | 1×7NH; | |||
| Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-D… |
Heteromer P13726; | 100 | 1×FUC; 2×CA; 1×BGC; 1×0GE; 1×CL; | |||
| Crystal structure of active site inhibited coagulation factor VIIA mutant in complex with soluble t… |
Heteromer P13726; | 100 | 1×GLC; 1×FUC; 1×CA; 1×0Z6; | |||
| Crystal Structure of a FVIIa-Trypsin Chimera (YT) in Complex with Soluble Tissue Factor |
Heteromer P13726; | 100.0 | 1×BGC; 1×FUC; 1×0Z6; 1×CA; 1×CIT; | |||
| Crystal Structure of tissue factor-factor VIIa complex |
Heteromer P13726; | 100 | 1×GLC; 1×FUL; 1×0Z6; 1×NAG; 1×CA; | |||
| Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue f… |
Heteromer P13726; | 100 | 1×BGC; 1×FUC; 1×CA; | |||
| Factor VIIa Inhibitors: Chemical Optimization, Preclinical Pharmacokinetics, Pharmacodynamics, and … |
Heteromer P13726; | 100 | 1×C1B; | |||
| Discovery of Novel Heterocyclic Factor VIIa Inhibitors |
Heteromer P13726; | 100 | 1×N1H; | |||
| STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE TRIGGERING OF BLOOD COAGULATION |
Heteromer | 100 | 1×NAG; 1×GLC; 1×FUC; 1×0Z6; 1×CA; | |||
| Factor VII binding Fab of the bispecific antibody HMB-001 in complex with Factor VII |
Heteromer P13726; | 100 | 2×CA; 1×BGC; | |||
| Factor VIIa in complex with the inhibitor 1-[(2R,15R)-2-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-4… |
Heteromer | 100 | 1×70C; 1×CA; 3×SO4; 2×GOL; | |||
| Factor VIIa in complex with the inhibitor 2-(2-{(R)-[(4-carbamimidoylphenyl)amino][5-ethoxy-2-fluor… |
Heteromer | 100 | 1×4K1; 1×CA; 4×SO4; 2×GOL; | |||
| Crystal Structure of Factor VIIa in complex with 1-(2,6-difluorophenyl)-3-[[3-[5-hydroxy-4-(1H-pyrr… |
Heteromer | 100 | 2×GOL; 1×CA; 1×CL; 2×SO4; 1×7ZP; | |||
| Crystal Structure of Factor VIIa in complex with N-(6-aminopyridin-3-yl)-5-hydroxy-1-phenylpyrazole… |
Heteromer | 100 | 2×SO4; 5×GOL; 1×CA; 3×CL; 1×7ZM; | |||
| Crystal Structure of Factor VIIa in complex with (2S)-2,3-dihydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[… |
Heteromer | 100 | 5×SO4; 2×GOL; 1×CA; 1×7Z7; 1×CL; | |||
| Crystal Structure of Factor VIIa in complex with 2-phenyl-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-… |
Heteromer | 100 | 2×GOL; 1×CA; 2×CL; 1×SO4; 1×9RP; | |||
| Crystal Structure of Factor VIIa in complex with (2S)-2-hydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-… |
Heteromer | 100 | 5×SO4; 2×GOL; 1×7YA; 1×CA; | |||
| Crystal Structure of Factor VIIa in complex with (2S)-2-hydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-… |
Heteromer | 100 | 2×GOL; 1×7ZD; 1×CA; 1×CL; 1×SO4; | |||
| Crystal Structure of Factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-2-[3-[(2-amino-2-… |
Heteromer | 100 | 4×GOL; 1×CA; 1×CL; 3×SO4; 1×7LR; 1×TFA; | |||
| Crystal Structure of Factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-2-[3-[(2-amino-2-… |
Heteromer | 100 | 3×GOL; 1×CA; 2×CL; 2×SO4; 1×7ZJ; | |||
| Crystal Structure of Factor VIIa in complex with phenylmethanamine;hydrochloride |
Heteromer | 100 | 2×GOL; 1×CA; 2×CL; 2×SO4; 1×ABN; | |||
| Crystal Structure of Factor VIIa in complex with N-[[4-(aminomethyl)-2-(2-amino-2-oxoethoxy)phenyl]… |
Heteromer | 100 | 1×CA; 2×SO4; 1×7YP; | |||
| Crystal Structure of Factor VIIa in complex with 2-[(1-aminoisoquinolin-6-yl)amino]-2-(3-ethoxy-4-p… |
Heteromer | 100 | 3×CL; 2×GOL; 1×CA; 1×SO4; 1×7ZA; | |||
| Crystal Structure of Factor VIIa in complex with 2-[(1-aminoisoquinolin-6-yl)amino]-2-(5-ethoxy-2-f… |
Heteromer | 100 | 3×CL; 2×GOL; 1×CA; 1×SO4; 1×7Z1; | |||
| Crystal Structure of Factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-2-(3-chlorophenyl… |
Heteromer | 100 | 1×7ZG; 2×SO4; | |||
| Crystal Structure of Factor VIIa in complex with 1-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)… |
Heteromer | 100 | 2×SO4; 3×GOL; 1×CA; 2×CL; 1×7ZY; | |||
| Crystal Structure of Factor VIIa in complex with 1-(1-aminoisoquinolin-6-yl)-3-benzylurea |
Heteromer | 100 | 2×CL; 1×7XJ; 1×CA; 4×SO4; | |||
| Factor VIIa in complex with the inhibitor (2R,15R)-2-[(1-aminoisoquinolin-6-yl)amino]-4,15,17-trime… |
Heteromer | 100.0 | 1×70A; 1×CA; 4×SO4; 2×GOL; | |||
| Crystal Structure of Factor VIIa in complex with benzenecarboximidamide |
Heteromer | 100 | 6×SO4; 4×GOL; 1×CA; 1×BEN; | |||
| Crystal Structure of Factor VIIa in complex with 1-[[3-[4-(5-amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-5… |
Heteromer | 100 | 2×SO4; 3×GOL; 1×9S1; 1×CA; 3×CL; | |||
| Crystal Structure of Factor VIIa in complex with N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)… |
Heteromer | 100 | 2×SO4; 3×GOL; 1×CA; 3×CL; 1×9RV; | |||
| Crystal Structure of Factor VIIa in complex with cyclohexylmethanamine |
Heteromer | 100 | 2×GOL; 1×CA; 4×CL; 1×AMC; 3×SO4; | |||
| Crystal Structure of Factor VIIa in complex with cyclohexanamine |
Heteromer | 100 | 2×GOL; 1×CA; 2×CL; 3×SO4; 1×HAI; | |||
| Crystal Structure of Factor VIIa in complex with 2-(4-ethoxy-3-methoxyphenyl)-2-(isoquinolin-6-ylam… |
Heteromer | 100 | 3×CL; 5×SO4; 1×GOL; 1×7LX; 1×CA; | |||
| Crystal Structure of Factor VIIa in complex with 1-[[3-[2-hydroxy-3-(1H-pyrrolo[3,2-c]pyridin-2-yl)… |
Heteromer | 100.0 | 1×7XD; 3×CL; 4×GOL; 1×CA; 2×SO4; | |||
| Crystal Structure of Factor VIIa in complex with 1H-benzimidazol-2-amine |
Heteromer | 100 | 4×AX7; 2×GOL; 1×CA; 2×CL; 2×SO4; | |||
| Crystal Structure of Factor VIIa in complex with isoquinoline-1,6-diamine |
Heteromer | 100 | 3×CL; 1×CA; 2×SO4; 1×7XM; | |||
| Crystal Structure of Factor VIIa in complex with (2R)-2-hydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-… |
Heteromer | 100 | 2×GOL; 1×7YJ; 1×CA; 2×CL; 1×SO4; | |||
| human factor VIIa in complex with 5-hydroxy-N-(4-oxo-3H-quinazolin-6-yl)-1-[3-[(phenylcarbamoylamin… |
Heteromer | 100 | 2×GOL; 1×7Y7; 1×CA; 1×CL; 2×SO4; | |||
| Structure of factor VIIA in complex with the inhibitor 2-{2-[(1-aminoisoquinolin-6-yl)carbamoyl]-6-… |
Heteromer | 100 | 1×1NK; 1×CA; 4×SO4; 3×GOL; | |||
| Crystal Structure of Factor VIIa in complex with 5-hydroxy-N-(3-oxo-1,2-dihydroisoindol-5-yl)-1-[3-… |
Heteromer | 100 | 3×SO4; 2×GOL; 1×CA; 1×CL; 1×7Z4; | |||
| human factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-1-[3-[[(3,5-dimethyl-1,2-oxazol-… |
Heteromer | 100 | 1×GOL; 1×CA; 1×CL; 2×SO4; 1×7YM; | |||
| Structure of factor VIIA in complex with the inhibitor (2R)-2-[(1-AMINOISOQUINOLIN-6-YL)AMINO]-2-[3… |
Heteromer | 100 | 1×1OK; 1×CA; 4×SO4; 4×GOL; | |||
| Structure of FACTOR VIIA in complex with the inhibitor BMS-593214 also known as 2'-[(6R,6AR,11BR)-2… |
Heteromer | 100 | 1×1GE; 1×CA; | |||
| Factor VIIa in complex with the inhibitor 1-[(2R,15R)-2-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-4… |
Heteromer | 100 | 1×70D; 1×CA; 4×SO4; 2×GOL; | |||
| Structure of factor VIIA in complex with the inhibitor 2-{2-[(3-carbamoylphenyl)carbamoyl]-6-methox… |
Heteromer | 100 | 1×1NL; 1×CA; 4×SO4; 3×GOL; | |||
| human factor VIIa in complex with 1-[[3-[5-hydroxy-4-(7H-pyrrolo[2,3-d]pyrimidin-6-yl)pyrazol-1-yl]… |
Heteromer | 100 | 1×GOL; 1×9RY; 1×CA; 1×CL; 2×SO4; | |||
| Factor VIIa in complex with the inhibitor (11R)-11-[(1-aminoisoquinolin-6-yl)amino]-16-(cyclopropyl… |
Heteromer | 100.0 | 1×7KR; 1×CA; 4×SO4; 3×GOL; | |||
| Factor VIIa in complex with the inhibitor (5R,11R)-11-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-16-… |
Heteromer | 100.0 | 1×7KS; 1×CA; 4×SO4; 4×GOL; | |||
| Factor VIIa in complex with the inhibitor (5R)-5-[(1-aminoisoquinolin-6-yl)amino]-19-(cyclopropylsu… |
Heteromer | 100.0 | 1×7KQ; 1×CA; 4×SO4; 3×GOL; | |||
| Structure of FACTOR VIIA in complex with the inhibitor (6S)-N-(4-CARBAMIMIDOYLBENZYL)-1-CHLORO-3-(C… |
Heteromer | 100 | 1×1GG; 1×CA; | |||
| Factor VIIA in complex with the inhibitor (2R,15R)-2-[(1-aminoisoquinolin-6-yl)amino]-8-fluoro-7-hy… |
Heteromer | 100 | 1×67O; 1×CA; 3×SO4; 1×MES; | |||
| FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-4,11-diazatricycl… |
Heteromer | 100.0 | 1×4T1; 1×CA; 3×SO4; 1×GOL; | |||
| Factor VIIa in complex with the inhibitor 4-{[(R)-[5-ethoxy-2-fluoro-3-(propan-2-yloxy)phenyl](4-ph… |
Heteromer | 100 | 1×4JY; 1×CA; 4×SO4; 3×GOL; | |||
| FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 4-BROMO-2-METHOXYPHENOL |
Heteromer | 100.0 | 1×3Z7; 1×CA; 4×SO4; 3×GOL; | |||
| FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-1H-INDOLE-2-CARBOXYLIC ACID |
Heteromer | 100.0 | 1×3ZB; 1×CA; 4×SO4; 2×GOL; | |||
| Factor viia in complex with the inhibitor (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(pr… |
Heteromer | 100 | 1×2KF; 1×CA; 4×SO4; 3×GOL; | |||
| Structure of factor VIIA in complex with the inhibitor (2R)-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-2… |
Heteromer | 100 | 1×1OJ; 1×CA; 4×SO4; 4×GOL; | |||
| Structure of factor VIIA in complex with the inhibitor 2-{2-[(4-carbamimidoylphenyl)carbamoyl]-6-me… |
Heteromer | 100 | 2×1NJ; 1×CA; 6×SO4; 1×GOL; | |||
| FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 7-chloro-3,4-dihydroisoquinolin-1(2H)-one |
Heteromer | 100.0 | 1×3Z8; 1×CA; 3×SO4; 1×GOL; | |||
| Factor viia in complex with the inhibitor (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(pr… |
Heteromer | 100.0 | 1×2KE; 1×CA; 5×SO4; 1×GOL; | |||
| Factor VIIa in complex with the inhibitor 3'-amino-5'-[(2s,4r)-6-carbamimidoyl-4-phenyl-1,2,3,4-tet… |
Heteromer | 100 | 1×1T7; 1×CA; | |||
| Crystal structure of active site-inhibited human coagulation factor VIIA (DES-GLA) |
Heteromer | 100 | 1×0GE; 1×CA; | |||
| Factor VIIa in complex with the inhibitor 3-{[(2R)-17-ethyl-4-methyl-3,12-dioxo-7-[(propan-2-yl)sul… |
Heteromer | 100.0 | 1×82J; 1×CA; 4×SO4; 2×GOL; | |||
| human factor VIIa in complex with 1-[[3-[5-hydroxy-3-methyl-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazo… |
Heteromer | 100 | 2×GOL; 1×9RS; 1×CA; 2×CL; 1×SO4; | |||
| FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (methyl {3-[(2R)-1-{(2R)-2-(3,4-dimethoxyphenyl)-2-[(1-ox… |
Heteromer | 100 | 1×3Z9; 1×CA; 3×SO4; 2×GOL; | |||
| FACTOR VIIA IN COMPLEX WITH THE INHIBITOR N-{3-[(2R)-1-{(2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-p… |
Heteromer | 100 | 1×4T0; 1×CA; 3×SO4; | |||
| human POGLUT1 in complex with Factor VII EGF1 and UDP |
Heteromer Q8NBL1; | 100 | 3×NAG; 1×UDP; 1×CL; 2×GOL; 1×CA; | |||
| Cofactor-and substrate-assisted activation of factor VIIa | homo-2-mer | 100 | 4×SO4; 1×CA; 1×BEN; 1×GOL; | |||
| Factor7 - 413 complex | homo-2-mer | 100.0 | 1×CA; 1×413; | |||
| Crystal structure of uninhibited factor VIIa | homo-2-mer | 100 | 1×CA; 1×EDO; | |||
| Orally available Factor7a inhibitor | homo-2-mer | 100 | 1×346; 1×SO4; 1×CA; | |||
| Factor7 - 413 complex | homo-2-mer | 100.0 | 2×GOL; 1×CA; 1×413; 4×SO4; | |||
| Short Factor VIIa with a small molecule inhibitor | homo-2-mer | 100 | 2×CA; 7×SO4; 1×905; | |||
| Coagulation Factor VII Zymogen (EGF2/Protease) in Complex with Inhibitory Exosite Peptide A-183 | homo-2-mer | 100.0 | 1×SO4; 1×BEN; | |||
| THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, 20 STRUCTURES | monomer | 100 | ||||
| THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII (FUCOSYLATED AT SER-60), NMR, 20 STRUCT… | monomer | 100 | 1×FUC; | |||
| THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII (FUCOSYLATED AT SER-60), NMR, MINIMIZED… | monomer | 100 | 1×FUC; | |||
| THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, MINIMIZED AVERAGE STRUCTURE | monomer | 100 | ||||
| N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES | monomer | 100 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 9cli.1.D | monomer | 0.70 | 42.26 | |||
2 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 9cli.1.D | monomer | 0.70 | 41.95 | |||
| Isoform 2 | 9cls.1.D | monomer | 0.52 | 1×CA; | 34.31 | ||